Back to Search
Start Over
COL11A1 as an novel biomarker for breast cancer with machine learning and immunohistochemistry validation
- Publication Year :
- 2022
- Publisher :
- Freie Universität Berlin, 2022.
-
Abstract
- Machine learning (ML) algorithms were used to identify a novel biological target for breast cancer and explored its relationship with the tumor microenvironment (TME) and patient prognosis. The edgR package identified hub genes associated with overall survival (OS) and prognosis, which were validated using public datasets. Of 149 up-regulated genes identified in tumor tissues, three ML algorithms identified COL11A1 as a hub gene. COL11A1was highly expressed in breast cancer samples and associated with a poor prognosis, and positively correlated with a stromal score (r=0.49, p
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....253c4000c46f198eb669ef4e8df8d888
- Full Text :
- https://doi.org/10.17169/refubium-36396